Articles on Technology, Health, and Travel
Reddit ctxr of Technology
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s still a tough environment for investors long Reddit penny stocks. A... InvestorPlace - Stock Market N...This reddit is for people who have received one or more Covid 19 vaccines and are having long term / long haul side effects "from an mRNA vaccine" that are similar to the effects of long haul Covid infection itself. After 2-3 months if your side effects still persist I feel it would be considered vaccine injury."Frontiers in Immunology1, a leading peer-reviewed journal in the immunology field." LMAO, nope!Currently unable to complete any CTXR orders on Degiro, met with message "Unfortunately this product is not available for trading". Anyone know why? Our risk department has close the buy side for this product as the volume and price are really low. For now you won't be able to increase your position but if you wish you can sell it at any moment.News. TLDR: Approximately 1.5m warrants were scheduled to expire on April 5, 2024. The company extended the expiration date to April 5, 2025. << Link to 8-K filing >>. BACKGROUND: In April 2019, CTXR did a $5.3m offering. A total of 3,430,421 shares were issued. The offering also included warrants with a $1.42 exercise price.Link to Earnings Release. Link to 10-Q. $29.1 million in cash and cash equivalents as of March 31, 2023; $15 million registered direct offering in May 2023 extends runway through May 2024Welcome to r/gnus_stock! This is a subreddit dedicated to investor discussion and strategies related to the stock of Genius Brands International Inc, a children's media and distribution company based out of Beverly Hills, California.Cordomver. • 3 yr. ago. From Wikipedia :) "A data monitoring committee (DMC) – sometimes called a data and safety monitoring board (DSMB) – is an independent group of experts who monitor patient safety and treatment efficacy data while a clinical trial is ongoing." At several interval points during the study, this DMC does a read out of ...Posted by u/FFighterFarm - No votes and no commentsWhy Citius Pharmaceuticals Stock Is Plunging Today? 9:55 am, July 31, 2023 Portfolios: Bio Tickers: CTXR Read the full article The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Application (BLA) seeking approval for denileukin diftitox (Lymphir), an engineered IL-2-diphtheria toxin fusion …It depends, If the DMC declares Citius can end the phase 3 trial early, Citius can then move forward with FDA approval, hopefully with approval around late Q4 2021, early Q1 2022 the price will hit 6-9, but determing price depends if their is an increase in outstanding shares or not. As a vote is still in play for it and due in late May.The idea may be crazy. I think if a preliminary agreement was made for Minolok with a large investor company covering a 5-year license and sales right for the future, if 80-100 million dollars were put into the coffers with 50/50 ratios, would it be possible for the license and retail.xxjohnnybravoxx. • 10 mo. ago. Correct however so far 72 events happened with 152 patients thats around 47% of events occurring per patient thats why out of 17 patients 8 of them would of met with events. You might want to join ctxr discord as more details are talked about than reddit. 1.Are you looking for an effective way to boost traffic to your website? Look no further than Reddit.com. With millions of active users and countless communities, Reddit offers a uni...Posted by u/pxs2020 - 58 votes and 15 commentsCTXR is my largest swing trade. Mino-lok has a market value of 1.5B in the US alone. Then introduce the worlds market.... its current market cap is 450m at a $3.60 share price. so let's value the company at 1B..that's a share price of $7.20 +/-... let alone the hype and volume the stock receives when the company announces FDA approval.8.9K subscribers in the CTXR community. $CTXR - Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in…Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock SolutionIve seen it like in 2021 lol but its one of those AI generated responses on a website to make the website seem like they have knowledge of every stock like some articles you get about ctxr that talk about general shit and have a title of "why ctxr can go 10x in 2023" then you open the article and it just says general shitView community ranking In the Top 10% of largest communities on Reddit. Updated Corporate Presentation Sept 11, 2023 . Presentation updated: <<download link>> I ... Ideally, a partnership monetizing Halo Lido bumps CTXR price once, and then top line readership of ML rockets it further. Gonna stay holding.u/cicibarzo: $CTXR and $SPRT investor.Everyone take a deep breath. This isn't a squeeze play, momentum play, swing trade, this is real investment in a company. Nothing has changed about the end game, the only change is the number dropping (again). Just sit and wait for the real catalysts. 36 Share.The last time CTXR flew the warrants flew with it, going to 2.9 and 2.89 respectively. Right now CTXR is 2.12 and getting good momentum, is there a reason Not to buy these cheap warrants at 1.09? If citius flies, the warrants are exercisable at $4.125 each. Lmk if I am missing something.The Real Housewives of Atlanta; The Bachelor; Sister Wives; 90 Day Fiance; Wife Swap; The Amazing Race Australia; Married at First Sight; The Real Housewives of Dallascheers to a great month, folks! Been holding for 2 years, rode out the peak up to 4, didn't sell and held since. Been a long journey back to my $1.65 average but 2023 seems to be the year of Citius! Holy shit - I been sitting at $1.75 for years. Come pick a playa up. Well good so far.IRC reported ORR was 36.2%. Lower limit of the CI was 25%. Upper limit was 48.7% They barely met their threshold for efficacy. Which was defined as the lower limit of the CI exceeding 25.0%.View community ranking In the Top 10% of largest communities on Reddit. Ctxr discord. discord.gg. Its probably the best out of all ctxr talk related platforms. comment sorted by Best Top New Controversial Q&A Add a Comment [deleted] • Additional comment actions ...August PDUFA for Lymphir gives CTXR roughly 5 months to execute the Citius Oncology spinoff and avoid the milestone payments owed to Eisai & Dr Reddy. Even if the spinoff gets delayed, an August approval decision provides a buffer. Now we sit and wait for Mino-Lok topline. May or June.CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial for Mino ...Lots of euphoria on this sub today folks. Don't get sucked in. This is CLASSIC biotech play by those looking to pump the stock on open so they can short the living crap out of it the moment they can.You were all told that the capital raise was to cover R&D costs for the various trials and NDA applications through 2023 and beyond. Yet here they are spending $40m upfront, another $40m in R&D costs for Dr Reddy, potentially another $70m depending on milestones. Enjoy the next $100m offering where they dilute you another significant …Financial Overview. At the end of Q2 2023, CTXR held $33.3 million in cash and equivalents, with total current assets reaching $41.1 million. This was set against a net loss of $8.5 million....Welcome to r/wsbafterhours, where the spirit of bold market plays lives on. This is a sanctuary for those who appreciated the original WSB vibe but prefer a refined focus, steering clear of international and meme stocks.Positive Outlook for Citius Pharmaceuticals with Lymphir’s FDA Resubmission and Market PotentialView community ranking In the Top 10% of largest communities on Reddit Citius resubmits previously approved drug ONTAK in the form of I-ONTAK (E7777) Denileukin Diftitox to FDAThis is the day that FTSE Russell ranks US companies to determine the composition of its US indexes. Last year, CTXR was included in the Russell 2000 and 3000 indexes. However, this year doesn't look too good. A stock must be above $1 just to be eligible for consideration. Unless something drastic happens by Tuesday, CTXR will likely not be ...Nexo is the world's leading regulated digital assets institution. The company's mission is to maximize the value and utility of digital assets through our comprehensive product suite including advanced trading solutions, liquidity aggregation, tax-efficient asset-backed credit lines, a high-yield Earn Interest product, as well as the Nexo Platform and Nexo Wallet with their top-tier ...If HL was finished and had top line data, maybe it could be out licensed and CTXR wouldn't need to spin off Iontak for the cash. But Iontak requires some big payments in the near future, so spinning it off would actually most likely help CTXR share price. ... A small place on the internet where reddit users discuss their trades and positions.External DD & Reddit Posts. Q2 2022 Business Update & Upcoming Milestones. Extensive DD by FrugalNorwegian. CTXR Video by TheWalrus Street. Dawson James CTXR analyst research note. Their current PT is $10. All in ONE DD - everything you need to know ahead of CTXR investing. New to Pharma? Read up on the different clinical phases!NASDAQ Compliance. Deadline to regain compliance with NASDAQ's minimum bid price rule is Sept 9th . Extension received on March 12 . CTXR regains compliance after closing above $1 for ten consecutive trading days. Aug 26 - …August PDUFA for Lymphir gives CTXR roughly 5 months to execute the Citius Oncology spinoff and avoid the milestone payments owed to Eisai & Dr Reddy. Even if the spinoff gets delayed, an August approval decision provides a buffer. Now we sit and wait for Mino-Lok topline. May or June.One attorney tells us that Reddit is a great site for lawyers who want to boost their business by offering legal advice to those in need. If you’re a lawyer, were you aware Reddit ...Link to Mino-Lok India Trial. The Mino-Lok trial in India was posted today. CTXR previously announced that they would work with Biorasi and add international sites to support trial completion by end of 2022. Previously, I uploaded a LinkedIn post that suggested India would be one of Biorasi's trial locations. So far, I have not found information on any other international sites.Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program true After setting aside the feature as a paid perk, Reddit 32 votes, 28 comments. Hey Folks! Moving a little sideFind the latest Citius Pharmaceuticals, In
Health Tips for Page laundromat
CRANFORD, N.J., July 7, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell ...Get the latest Citius Pharmaceuticals, Inc. (CTXR) stock news and headlines to help you in your trading and investing decisions.CTXR has 3 products in the pipeline. We are obviously all waiting on ML as this is the catalyst for company growth and market increase. I suspect the oncology product ends up as an overall profit for the company when all is said and done, but nothing needle moving.On March 12, 2024, Citius Pharmaceuticals, Inc. (the "Company") received formal notice that the Nasdaq Stock Market LLC ("Nasdaq") granted our request for an extension through September 9, 2024 (the "Extension Notice") to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market ...Halo-Lido results in Q2 2023. I/ONTAK FDA approval decision by July 28, 2023. These catalysts are still up in the air. Hopefully we get some sort of update soon. Mino-Lok update/progress. Last update in December 2022 said they had 72 events, 152 patients completed the trial, and 17 patients still active.Update from Sushi (of Stocktwits Fame) regarding CTXR - He called investor relations this morning 👌Amended 13G filing from Blackrock. In Feb they reported over 8m shares, 5.6% ownership. Now they are down to over 2m shares, 1.3% ownership. Reduction is related to CTXR'S removal from the Russell 2000 & 3000 indexes last month.Future filings from CTXR will likely detail the specifics of any share distributions. Up to 10% of the shares CTXR receives will be distributed to shareholders-History of the Transaction: Pages 131-136 cover the background of the combination. I won't go over in detail, but it's an interesting read.I currently own 7,000 shares of CTXR at a cost basis of $1.25 and it is still an absolute steal at $1.64 Volume for calls at the $2.50 strike price expiring in the next 6 months is at an all time high. A spinoff for the company's I/ONTAK division was announced on March 30th and will expand into India's pharmaceutical market.Current Mino-Lok Numbers vs their Original Projections. An In-Depth Analysis. DD. Thanks to the Earnings Release, we finally have some concrete numbers to indicate the current progress of the Mino-Lok trial. 169 patients enrolled so far, with 152 completed & 17 active participants. Of the 152 completed patients, 72 had a catheter failure event ...Get the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.xxjohnnybravoxx. • 10 mo. ago. Correct however so far 72 events happened with 152 patients thats around 47% of events occurring per patient thats why out of 17 patients 8 of them would of met with events. You might want to join ctxr discord as more details are talked about than reddit. 1.A celebrity or professional pretending to be amateur usually under disguise. The video has to be an activity that the person is known for. For example, a professional tennis player pretending to be an amateur tennis player or a famous singer smurfing as an unknown singer.47 votes, 44 comments. I bought ctxr around 1.68-1.70 and I've held all the way up to 4 and all the way back where we currently are. Nothing got…So basically, Mino-Lok, no, we are about salvaging the catheters. So basically, part of that indication is going to read that the catheter itself does not have to be subjected to a remove and replace. Thank you very much. So, it's keeping that catheter intact. 2) The separation of the two entities.Is there a hidden cure for cancer? HowStuffWorks looks into the conspiracy theory that Big Pharma is hiding the cure for cancer. Advertisement You've probably heard this conspiracy...As I previously posted, CTXR is an exhibitor this year, booth 3354. I suspect that we may see an abstract or poster on lymphomas/Lymphir (E7777). Perhaps some additional subgroup analysis of the CTCL data.From the article you shared. A drug that receives Fast Track designation is eligible for the following: More frequent meetings with FDA to discuss the drug's development plan and ensure collection of appropriate data needed to support drug approval;Terrible April fools joke. Guys. We're almost at a dollar. This isn't funny.Posted by u/SaltyTsunami - 39 votes and 260 commentsQuestion asked if CTXR plans to market all drugs themselves. Says that they will do what is best for shareholders and the company. Halo-Lido will most likely not be taken to market by CTXR. Expenditures for sales & marketing of that type of drug will be too large for them. They plan to out-license Halo-Lido once they have phase 2b data.I got out when they announced the delay in getting people signed up. I think 1.50 to 1.60 is a great entrance point. follow the sentiment of a stock as much as the stock. even this board has grown quite on this. great stock for a couple years down the road and we are in a instant profit place in the market.On March 12, 2024, Citius Pharmaceuticals, Inc. (the "Company") received formal notice that the Nasdaq Stock Market LLC ("Nasdaq") granted our request for an extension through September 9, 2024 (the "Extension Notice") to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market ...New SEC Filing today. Dennis McGrath received 75,000 +27% Year-to-date, +40% over last 6 months, +2
Top Travel Destinations in 2024
A: short minded. They cant see the overall picture. They dont think about 6month-1 year from now but whats happening now. Also a lot of people mix large caps with penny stocks.. not only are we penny stock but we are a biotech sNASDAQ Compliance. Deadline to regain compliance with NASDAQ's minimum bid price rule is Sept 9th . Extension received on March 12 . CTXR regains compliance after closing above $1 for ten consecutive trading days. Aug 26 - Sept 9 is the last 10 day trading period for compliance.May 8, 2022 · Reddit Stocks: Citius Pharmaceuticals (CTXR) an image of a microscope. Source: Shutterstock. Citius Pharmaceuticals (NASDAQ:CTXR) is a small biotech with no revenues or profits but hopes to move ...I expect they will hold a pre-NDA with the FDA also. This will be a key meeting for CTXR to have a full understanding of the NDA submission requirements before they actually complete the submission. Mino-Lok was granted fast track status. Which means they may be eligible for things like a rolling NDA submission and a Priority Review. Key word ...View community ranking In the Top 10% of largest communities on Reddit r/CTXR Lounge comments sorted by Best Top New Controversial Q&A Add a CommentYou were all told that the capital raise was to cover R&D costs for the various trials and NDA applications through 2023 and beyond. Yet here they are spending $40m upfront, another $40m in R&D costs for Dr Reddy, potentially another $70m depending on milestones. Enjoy the next $100m offering where they dilute you another significant amount.CTXR is my largest holding average price I'm in at 1.97 been holding for months thru the ups and downs. Once mino lok passes approval around June 28 not sure on the date it should be a matter of time before this stock shines. Analysts already have price target at $6.00. Ive done my dd and I'm in for the long haul on this play....Track Citius Pharmaceuticals Inc (CTXR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsJune 1 2021 (HYPE) Discussion. Hey Folks! Long weekend over guess what... It's June! Time flies! I can only imagine what this month might have in store for us. Welcome to the CTXR Daily Discussion Thread! Use this for all your …The Real Housewives of Atlanta; The Bachelor; Sister Wives; 90 Day Fiance; Wife Swap; The Amazing Race Australia; Married at First Sight; The Real Housewives of DallasOn March 12, 2024, Citius Pharmaceuticals, Inc. (the "Company") received formal notice that the Nasdaq Stock Market LLC ("Nasdaq") granted our request for an extension through September 9, 2024 (the "Extension Notice") to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market ...Action Movies & Series; Animated Movies & Series; Comedy Movies & Series; Crime, Mystery, & Thriller Movies & Series; Documentary Movies & Series; Drama Movies & SeriesWelcome to the CTXR Daily Discussion Thread! Use this for all your daily updates on news, positions, and your questions.Posted by u/ThatOneGuyWithABBC - 1 vote and no comments6 of the stocks I currently own, including Citius, made the Russell 3000 addition list. Does anyone have any research on what impact in terms of price movement that has on stocks?AMC Entertainment is stealing the spotlight again....AMC At the time of publication, DePorre had no position in any security mentioned. The biggest investing and trading mistake th...8.9K subscribers in the CTXR community. $CTXR - Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR…From what I've read (no expert) a spac is valuing the cancer drug at $675 million, and is merging with citius oncology.Normal week with 100% Citius holdings: Monday: CTXR +0.5%. Today is a good day! Tuesday: CTXR -2%. Shit, people are shorting my stock. I hate today.With their acquisition of I/ONTAK (E7777), I'd be surprised if they don't pursue future possibilities in oncology. Use revenue from Mino-Lok, the CTCL indication for I/ONTAK, and the rest of their current pipeline (i.e. potential licensing for Halo-Lido) to fund those trials.The difference with mino-lok and other company products is that mino-lok is the only product available in a 1.5billion dollar market, now that doesn't mean it'll capture 100% of the market, however because its the only product itll capture the most and the market cap of CTXR is around 300mil at 2$. 1.2bil = 8$ price tag and thats only the 1 ...Posted by u/SaltyTsunami - 39 votes and 260 commentsNews. Dawson James terminated coverage of CTXR on April 1st. The analyst covering CTXR for Dawson James, Jason Kolbert, is no longer employed. Download here --> Dawson James Termination Report. Effective upon this termination of coverage, investors should no longer rely on any of our prior research, financial estimates, or ratings.CTXR is getting punished for some stupid PR decisions, and rightfully so, but that doesn't have an impact on the value of the drugs on offer should they clear the FDA. And that's what you invested in, the drugs hopefully, not a poorly worded forward guidance. ... Don't really care about Reddit tbh but I enjoy listening on discord way too much ... Welcome to the Weekly Discussion Thread! Please use this